Calidi Biotherapeutics, Inc. (CLDI)

USD 1.44

(-16.76%)

Gross Profit Summary of Calidi Biotherapeutics, Inc.

  • Calidi Biotherapeutics, Inc.'s latest annual gross profit in 2023 was -1.25 Million USD , down -448.47% from previous year.
  • Calidi Biotherapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was -378 Thousand USD , down -1.07% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported a annual gross profit of -229 Thousand USD in annual gross profit 2022, down -164.51% from previous year.
  • Calidi Biotherapeutics, Inc. reported a annual gross profit of 355 Thousand USD in annual gross profit 2021, down 0.0% from previous year.
  • Calidi Biotherapeutics, Inc. reported a quarterly gross profit of -374 Thousand USD for 2024 Q1, down -2.75% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported a quarterly gross profit of -364 Thousand USD for 2023 Q4, down -264.0% from previous quarter.

Annual Gross Profit Chart of Calidi Biotherapeutics, Inc. (2023 - 2020)

Historical Annual Gross Profit of Calidi Biotherapeutics, Inc. (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 -1.25 Million USD -448.47%
2022 -229 Thousand USD -164.51%
2021 355 Thousand USD 0.0%
2020 - USD 0.0%

Peer Gross Profit Comparison of Calidi Biotherapeutics, Inc.

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD 885.0%
Ampio Pharmaceuticals, Inc. -250 Thousand USD -402.4%
Armata Pharmaceuticals, Inc. -29.24 Million USD 95.705%
Actinium Pharmaceuticals, Inc. -709 Thousand USD -77.151%
Azitra, Inc. 260.45 Thousand USD 582.24%
Can-Fite BioPharma Ltd. 743 Thousand USD 269.044%
Chromocell Therapeutics Corporation -2.57 Million USD 51.307%
CEL-SCI Corporation -3.95 Million USD 68.269%
iBio, Inc. -1.02 Million USD -22.537%
Lineage Cell Therapeutics, Inc. 8.27 Million USD 115.18%
MAIA Biotechnology, Inc. - USD Infinity%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 90.622%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -952.852%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD 115.909%
NanoViricides, Inc. -759.01 Thousand USD -65.478%
Oragenics, Inc. -15.45 Million USD 91.872%
BiomX Inc. -1.22 Million USD -2.28%
BiomX Inc. -1.22 Million USD -2.28%
Protalix BioTherapeutics, Inc. 42.51 Million USD 102.954%
Palatin Technologies, Inc. 4.39 Million USD 128.595%
Scorpius Holdings, Inc. -2.21 Million USD 43.332%